Valuation Redcare Pharmacy NV OTC Markets

Stocks

Market Closed - OTC Markets 14:30:15 22/10/2026 BST			5-day change	1st Jan Change
8.630 ^USD	+5.24%		+5.24%	+15.07%

10-14	Redcare Pharmacy N.V. Announces Appointment of Peter Schmid von Linstow as Chief Executive Officer, Effective October 14, 2026	CI
10-14	Redcare Pharmacy N.V. Announces Appointment of Peter Schmid von Linstow as Member of the Managing Board, Effective October 14, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,050	798.2	2,395	2,679	1,324	1,603	-	-
Change	-	-61.07%	200.06%	11.86%	-50.57%	21.05%	-	-
Enterprise Value (EV) ¹	2,039	986.6	2,556	2,830	1,648	1,838	1,826	1,788
Change	-	-51.62%	159.04%	10.72%	-41.74%	11.47%	-0.64%	-2.04%
P/E	-27.3x	-10.2x	-180x	-58x	-34.8x	-148x	68.4x	28.5x
PBR	4.94x	2.26x	5.09x	5.54x	2.85x	3.37x	3.16x	2.81x
PEG	-	-2.49x	2.2x	-0x	2x	2.1x	-0x	0x
Capitalization / Revenue	1.93x	0.66x	1.33x	1.13x	0.45x	0.46x	0.42x	0.38x
EV / Revenue	1.92x	0.82x	1.42x	1.19x	0.56x	0.53x	0.47x	0.42x
EV / EBITDA	-408x	-123x	47.8x	85x	28.7x	19.1x	13.8x	10.5x
EV / EBIT	-63.1x	-20.7x	-674x	-81x	-135x	72.7x	30x	18.4x
EV / FCF	-64.7x	-11.9x	110x	-141x	-18.8x	-40.8x	139x	38x
FCF Yield	-1.55%	-8.38%	0.91%	-0.71%	-5.31%	-2.45%	0.72%	2.63%
Dividend per Share ²	-	-	-	-	-	0.00667	-	-
Rate of return	-	-	-	-	-	0.01%	-	-
EPS ²	-4.15	-4.32	-0.73	-2.27	-1.87	-0.5267	1.138	2.736
Distribution rate	-	-	-	-	-	-1.27%	-	-
Net sales ¹	1,060	1,204	1,799	2,371	2,941	3,454	3,854	4,249
EBITDA ¹	-5	-8.044	53.5	33.3	57.4	96.06	132.5	170.1
EBIT ¹	-32.3	-47.55	-3.793	-34.91	-12.2	25.29	60.87	97.34
Net income ¹	-74.2	-77.65	-12.04	-45.46	-37.7	-10.31	28.07	61.17
Net Debt ¹	-10.98	188.4	160.7	150.5	324.2	234.5	222.7	185.4
Reference price ²	113.30	44.11	131.60	131.70	65.10	77.90	77.90	77.90
Nbr of stocks (in thousands)	18,095	18,095	18,199	20,342	20,342	20,578	-	-
Announcement Date	02/03/22	07/03/23	05/03/24	11/03/25	03/03/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JD HEALTH INTERNATIONAL INC.	17.04x	0.7x	10.38x	-.--%	15.29B
RAIA DROGASIL S.A.	23.58x	0.98x	10.61x	1.91%	7.04B
MATSUKIYOCOCOKARA & CO.	17.07x	0.76x	7.93x	2.19%	6.58B
TSURUHA HOLDINGS INC.	21.05x	0.36x	5.64x	2.17%	6.44B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	19.76x	0.72x	12.44x	1.1%	5.91B
YIFENG PHARMACY CHAIN CO., LTD.	16.3x	1.02x	7.13x	2.59%	4.61B
COSMOS PHARMACEUTICAL CORPORATION	15.66x	0.46x	7.59x	1.34%	3.21B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	13.93x	0.59x	4.53x	5.19%	3.1B
CLICKS GROUP LIMITED	14.97x	0.89x	6.68x	4.33%	3.02B
Average	17.71x	0.72x	8.10x	2.31%	6.13B
Weighted average by Cap.	18.21x	0.72x	8.82x	1.7%